TABLE 4.
All (N = 144) | AVNRT (N = 78) | AVRT (N = 51) | AT (N = 15) | P value | |
---|---|---|---|---|---|
RF application number | 8 (5‐13) | 8 (5‐14) | 8 (5‐12) | 8 (6‐16) | .76 |
RF application time (sec) | 340 (217‐490) | 323 (200‐441) | 357 (226‐533) | 462 (305‐825) | .68 |
ISP dose for reinduction (mg/h) | 0.06 (0‐0.06) | 0.06 (0.03‐0.06) | 0.03 (0‐0.06) | 0.06 (0.06‐0.18) | .0002 |
Propofol dose (mg) | 280 (200‐400) | 280 (180‐360) | 280 (210‐460) | 300 (230‐540) | .11 |
Dexmedetomidine dose (μg) | 152 (124‐192) | 140 (120‐184) | 156 (132‐212) | 160 (136‐244) | .063 |
Fluoroscopy time (min) | 24 (17‐33) | 23 (15‐34) | 27 (20‐33) | 26 (18‐33) | 1 |
Total procedure time (min) | 169 (136‐205) | 157 (132‐191) | 175 (146‐202) | 218 (141‐288) | .0081 |
ASV time (min) | 167 (138‐205) | 152 (134‐192) | 148 (180‐203) | 257 (164‐296) | <.0001 |
Time for EPS (min) | 113 (91‐138) | 104 (88‐130) | 121 (95‐139) | 133 (93‐197) | .029 |
Systolic BP at the end of procedure | 119 (107‐131) | 121 (131‐106) | 119 (107‐135) | 114 (110‐123) | .75 |
Diastolic BP at the end of procedure | 74 (64‐80) | 72 (62‐81) | 75 (64‐81) | 68 (65‐79) | .61 |
HR at the end of procedure | 64 (58‐72) | 65 (60‐73) | 61 (56‐68) | 72 (60‐87) | .007 |
Complication | 4 (3%) | 2 (3%) | 1 (2%) | 1 (7%) | .61 |
Abbreviations: RF, radiofrequency; ISP, isoproterenol; BP, blood pressure; HR, heart rate.
Values less than 0.05 are written in bold.